Pharvaris N.V. Quarterly Research And Development Expense in EUR from Q2 2021 to Q2 2023

Taxonomy & unit
ifrs-full: EUR
Summary
Pharvaris N.V. annual/quarterly Research And Development Expense history and growth rate from Q2 2021 to Q2 2023.
  • Pharvaris N.V. Research And Development Expense for the quarter ending June 30, 2023 was €14.7M, a 7% increase year-over-year.
  • Pharvaris N.V. annual Research And Development Expense for 2023 was €65.6M, a 14.3% increase from 2022.
  • Pharvaris N.V. annual Research And Development Expense for 2022 was €57.4M, a 60.3% increase from 2021.
  • Pharvaris N.V. annual Research And Development Expense for 2021 was €35.8M, a 83.5% increase from 2020.
Research And Development Expense, Quarterly (EUR)
Research And Development Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 14.7M +960K +7% Apr 1, 2023 Jun 30, 2023 6-K 2023-08-07
Q2 2022 13.7M +5.66M +70.2% Apr 1, 2022 Jun 30, 2022 6-K 2023-08-07
Q2 2021 8.06M Apr 1, 2021 Jun 30, 2021 6-K 2022-09-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.